Enabling India
- All
- News
- Videos
-
Ozempic Copycats Arrive: From Rs 11,000 To Rs 3,000, How Patent Expiry Is Reshaping Diabetes Treatment
- Saturday March 21, 2026
- Health | Reported by Tanushka Dutta
With patent protection ending, Indian companies have moved quickly to introduce lower-cost versions with monthly therapy expected at around Rs 3,000 to Rs 4,000 for initial doses
-
www.ndtv.com
-
IIT Jodhpur Develops Flexible Sensors For Early Cancer Detection
- Friday March 20, 2026
- Health | Indo-Asian News Service
Jaipur, March 19 (IANS) Researchers at the Indian Institute of Technology (IIT) Jodhpur are developing next‑generation flexible semiconductor devices designed for continuous health monitoring, early disease detection and physiological assessment in d
-
www.ndtv.com
-
Semaglutide Is Not A Quick Fix: Bariatric Surgeon Explains The Right Way To Use It
- Thursday March 19, 2026
- Health | Written by Dr Kona Lakshmi Kumari
With generics poised to make semaglutide widely accessible in India, this medication has the potential to transform obesity care. But it cannot replace personalised, long-term treatment plans.
-
www.ndtv.com
-
From Diabetes To Weight Loss: How Semaglutide Became The Blockbuster Behind Ozempic, Wegovy
- Wednesday March 18, 2026
- Health | Written by Shreya Goswami
From a diabetes drug to a global weight-loss phenomenon, semaglutide has reshaped modern medicine. As patents expire, cheaper versions may expand access, raising questions about affordability, safety and long-term impact.
-
www.ndtv.com
-
3 Complex Surgeries, 3 Robots, 1 Day: How Robotics Is Changing The Way Joint Surgeries Are Done
- Wednesday March 18, 2026
- Health | Written by Dr Sunil G Kini
Robot-assisted orthopedic surgery enables surgeons to plan surgeries with a level of accuracy that had been difficult before.
-
www.ndtv.com
-
Jio Reportedly Offers Free Incoming SMS Over VoWiFi Without Roaming Pack for International Travellers
- Wednesday March 18, 2026
- Written by Shaurya Tomer, Edited by Ketan Pratap
Reliance Jio is said to have announced a new benefit for international travellers. According to a report, the telecom service provider (TSP) now offers free incoming SMS support over Wi-Fi calling (VoWiFi) at no additional cost. Users can reportedly receive important messages abroad without requiring an active international roaming (IR) pack. The m...
-
www.gadgets360.com
-
What Are Semaglutide Generics? Here's Why They Matter More In India Now
- Tuesday March 17, 2026
- Health | Written by Sambhav Kumar
Semaglutide works by imitating the natural hormone glucagon-like peptide-1 (GLP-1), which plays a key role in managing blood sugar.
-
www.ndtv.com
-
IndiGo, Adani Airport Launch Partnership For BluChips On Duty-Free Shopping
- Monday March 16, 2026
- India News | Asian News International
IndiGo and Adani Airport Holdings Limited (AAHL) have announced a strategic partnership enabling IndiGo BluChip members to earn on duty-free shopping across AAHL-managed airports.
-
www.ndtv.com
-
50+ Branded Semaglutide Generics To Enter India As Diabetes Drug Patent Expires In March 2026
- Monday March 16, 2026
- Health | Written by Sambhav Kumar
Semaglutide patent in India expires in March 2026, enabling over 50 branded generic versions to enter the market, likely reducing treatment costs for diabetes and obesity patients.
-
www.ndtv.com
-
Ozempic Copycats Arrive: From Rs 11,000 To Rs 3,000, How Patent Expiry Is Reshaping Diabetes Treatment
- Saturday March 21, 2026
- Health | Reported by Tanushka Dutta
With patent protection ending, Indian companies have moved quickly to introduce lower-cost versions with monthly therapy expected at around Rs 3,000 to Rs 4,000 for initial doses
-
www.ndtv.com
-
IIT Jodhpur Develops Flexible Sensors For Early Cancer Detection
- Friday March 20, 2026
- Health | Indo-Asian News Service
Jaipur, March 19 (IANS) Researchers at the Indian Institute of Technology (IIT) Jodhpur are developing next‑generation flexible semiconductor devices designed for continuous health monitoring, early disease detection and physiological assessment in d
-
www.ndtv.com
-
Semaglutide Is Not A Quick Fix: Bariatric Surgeon Explains The Right Way To Use It
- Thursday March 19, 2026
- Health | Written by Dr Kona Lakshmi Kumari
With generics poised to make semaglutide widely accessible in India, this medication has the potential to transform obesity care. But it cannot replace personalised, long-term treatment plans.
-
www.ndtv.com
-
From Diabetes To Weight Loss: How Semaglutide Became The Blockbuster Behind Ozempic, Wegovy
- Wednesday March 18, 2026
- Health | Written by Shreya Goswami
From a diabetes drug to a global weight-loss phenomenon, semaglutide has reshaped modern medicine. As patents expire, cheaper versions may expand access, raising questions about affordability, safety and long-term impact.
-
www.ndtv.com
-
3 Complex Surgeries, 3 Robots, 1 Day: How Robotics Is Changing The Way Joint Surgeries Are Done
- Wednesday March 18, 2026
- Health | Written by Dr Sunil G Kini
Robot-assisted orthopedic surgery enables surgeons to plan surgeries with a level of accuracy that had been difficult before.
-
www.ndtv.com
-
Jio Reportedly Offers Free Incoming SMS Over VoWiFi Without Roaming Pack for International Travellers
- Wednesday March 18, 2026
- Written by Shaurya Tomer, Edited by Ketan Pratap
Reliance Jio is said to have announced a new benefit for international travellers. According to a report, the telecom service provider (TSP) now offers free incoming SMS support over Wi-Fi calling (VoWiFi) at no additional cost. Users can reportedly receive important messages abroad without requiring an active international roaming (IR) pack. The m...
-
www.gadgets360.com
-
What Are Semaglutide Generics? Here's Why They Matter More In India Now
- Tuesday March 17, 2026
- Health | Written by Sambhav Kumar
Semaglutide works by imitating the natural hormone glucagon-like peptide-1 (GLP-1), which plays a key role in managing blood sugar.
-
www.ndtv.com
-
IndiGo, Adani Airport Launch Partnership For BluChips On Duty-Free Shopping
- Monday March 16, 2026
- India News | Asian News International
IndiGo and Adani Airport Holdings Limited (AAHL) have announced a strategic partnership enabling IndiGo BluChip members to earn on duty-free shopping across AAHL-managed airports.
-
www.ndtv.com
-
50+ Branded Semaglutide Generics To Enter India As Diabetes Drug Patent Expires In March 2026
- Monday March 16, 2026
- Health | Written by Sambhav Kumar
Semaglutide patent in India expires in March 2026, enabling over 50 branded generic versions to enter the market, likely reducing treatment costs for diabetes and obesity patients.
-
www.ndtv.com